Correlation Between BridgeBio Pharma and Regenxbio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and Regenxbio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and Regenxbio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and Regenxbio, you can compare the effects of market volatilities on BridgeBio Pharma and Regenxbio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of Regenxbio. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and Regenxbio.

Diversification Opportunities for BridgeBio Pharma and Regenxbio

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BridgeBio and Regenxbio is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and Regenxbio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenxbio and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with Regenxbio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenxbio has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and Regenxbio go up and down completely randomly.

Pair Corralation between BridgeBio Pharma and Regenxbio

Given the investment horizon of 90 days BridgeBio Pharma is expected to generate 1.45 times more return on investment than Regenxbio. However, BridgeBio Pharma is 1.45 times more volatile than Regenxbio. It trades about 0.06 of its potential returns per unit of risk. Regenxbio is currently generating about -0.02 per unit of risk. If you would invest  913.00  in BridgeBio Pharma on September 2, 2024 and sell it today you would earn a total of  1,796  from holding BridgeBio Pharma or generate 196.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BridgeBio Pharma  vs.  Regenxbio

 Performance 
       Timeline  
BridgeBio Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BridgeBio Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, BridgeBio Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Regenxbio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

BridgeBio Pharma and Regenxbio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BridgeBio Pharma and Regenxbio

The main advantage of trading using opposite BridgeBio Pharma and Regenxbio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, Regenxbio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenxbio will offset losses from the drop in Regenxbio's long position.
The idea behind BridgeBio Pharma and Regenxbio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins